Inception Return
(10/11/1994)
|
5.54 %
|
|
YTD Return
|
3.50 %
|
|
NAVPS
(7/21/2014)
|
$21.71
|
|
Change
|
$-0.10 / -0.47 %
|
|
|
Growth of $10,000
(As of June 30, 2014)
|
|
MER
|
2.52 %
|
|
Assets ($mil)
|
$81.14
|
|
Rank (1Yr)
|
82/85
|
|
Std Dev (3Yr)
|
8.32 %
|
|
Volatility Ranking (3Yr)
|
5/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Fees Front
|
-
|
|
Fees Back
|
-
|
|
Open to Invest
|
Open
|
|
|
Objective
This fund’s objective is to increase the value of your investment over the long term by investing in companies in Western Europe and the UK. As part of the investment objective, this fund invests primarily in companies that are listed on recognized exchanges and that will likely benefit from merger activity and reduced trade barriers as European markets and economies restructure. It may also invest in fixed-income securities issued by governments in Western Europe and the UK.
|
Management Co.
Vontobel Asset Management, Inc.
Managers
Rajiv Jain, Matthew Benkendorf, Daniel Kranson,
|
|
Asset Allocation
(As of June 30, 2014)
|
Sector Allocation
(As of June 30, 2014)
|
Geographic Allocation
(As of June 30, 2014)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Roche Holding AG - Participation | International Equity | Healthcare | Other European | 5.02% |
| British American Tobacco PLC - Common | International Equity | Consumer Goods | European Union | 4.84% |
| SABMiller PLC - Common | International Equity | Consumer Goods | European Union | 4.72% |
| Unilever NV - GDR | International Equity | Consumer Goods | European Union | 4.33% |
| Philip Morris International Inc - Common | US Equity | Consumer Goods | United States | 4.27% |
| Core Laboratories NV - Common | International Equity | Energy | European Union | 3.37% |
| Diageo PLC - Common | International Equity | Consumer Goods | European Union | 3.07% |
| Nestle SA - Common | International Equity | Consumer Goods | Other European | 3.07% |
| Novo Nordisk A/S - Common Cl B | International Equity | Healthcare | European Union | 3.06% |
| Grifols SA - Common | International Equity | Healthcare | European Union | 2.95% |
Performance Data
(As of June 30, 2014)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-1.70
|
-2.27
|
3.50
|
3.50
|
15.21
|
13.32
|
12.88
|
4.45
|
|
Benchmark
|
-1.73
|
-0.62
|
6.04
|
6.04
|
32.23
|
12.91
|
11.75
|
5.65
|
|
Quartile Ranking
|
3
|
4
|
3
|
3
|
4
|
1
|
1
|
2
|
|
Calendar Return (%)
|
2013
|
2012
|
2011
|
2010
|
2009
|
2008
|
2007
|
2006
|
2005
|
2004
|
|
Fund
|
18.77
|
21.77
|
1.80
|
4.59
|
13.68
|
-39.45
|
-8.87
|
33.95
|
7.31
|
15.90
|
|
Benchmark
|
35.86
|
17.02
|
-9.65
|
-0.64
|
18.93
|
-34.99
|
-3.33
|
35.67
|
6.54
|
12.72
|
|
Quartile Ranking
|
4
|
2
|
1
|
2
|
2
|
4
|
3
|
2
|
2
|
1
|